QR kȏd

Valvular Heart Disease Interventional Trials From 2000 to 2024

Background: Valvular heart disease (VHD) is a growing contributor to global cardiovascular morbidity, especially in aging populations. As transcatheter therapies expand, assessing enrollment trends and demographic representation is essential for equitable, generalizable evidence. Objectives: The pur...

Cijeli opis

Spremljeno u:
Glavni autori: Frederick Berro Rivera, MD, Chieh-Mei Tsai, MD, Polyn Luz S. Pine, MD, MBA, Nicole Tesoro, MD, John Vincent Magalong, MD, Nathan Ross B. Bantayan, BSc, Christine J. Lin, BA, Gabriel A. Tangco, MD, MBA, Abdullah Al-Abcha, MD, Mandeep Singh, MD, Mayra Guerrero, MD
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2026-01-01
Serija:JACC: Advances
Teme:
clinical trials
enrollment
sex disparities
trend
valvular heart disease
Online pristup:http://www.sciencedirect.com/science/article/pii/S2772963X25008142
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti